MedPath

Microbubble detection and ultrasound guided biopsy of armpit glands in patients with breast cancer

Phase 1
Conditions
Diagnosis of lymph node metastases in patients with newly diagnosed breast cancer.
MedDRA version: 14.1 Level: PT Classification code 10057654 Term: Breast cancer female System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
MedDRA version: 14.1 Level: LLT Classification code 10006203 Term: Breast cancer stage unspecified System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Therapeutic area: Diseases [C] - Cancer [C04]
Registration Number
EUCTR2012-001889-14-GB
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
139
Inclusion Criteria

To be included in the study the patients must:

- aged 18 years or over
- have biopsy proven invasive breast cancer
- have SLN biopsy recommended as part of their standard surgical management for breast cancer
- be able to give written informed consent
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 106
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 90

Exclusion Criteria

The presence of any of the following will preclude patient inclusion:

- unable to provide written informed consent
- aged 17 years or under
- history of previous ipsilateral breast cancer
- prior ipsilateral axillary surgery
- pregnant or lactating women

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath